Immucor Announces Fiscal First Quarter Results; EPS $.30

Loading...
Loading...
Immucor, Inc.
BLUD
, a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for its fiscal 2011 first quarter ended August 31, 2010. Highlights --Revenue for the first quarter of fiscal 2011 was $83.6 million, up 1% from $83.1 million in the prior year quarter. --Gross margin was 71.3% in the quarter compared with 71.9% in the prior year quarter. --Diluted earnings per share totaled $0.30 in the quarter compared with $0.30 for the same period last year. --Cash flow from operations for the quarter ended August 31, 2010 was $28.9 million compared with $24.5 million in the prior year. --Worldwide instrument orders for the first quarter of fiscal year 2011 were 26 Echo® orders and 18 NEO™ orders. NEO is the Company's new high volume instrument that is currently in the process of being launched worldwide.
Posted In: EarningsNewsHealth CareHealth Care Supplies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...